Published in Br J Ophthalmol on May 01, 1998
Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis. Br J Ophthalmol (2003) 2.20
Behçet's disease: a new target for anti-tumour necrosis factor treatment. Ann Rheum Dis (2002) 1.27
Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients. Br J Ophthalmol (2006) 1.18
Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation. Eye (Lond) (2011) 1.10
Ischemic retinal vasculitis and its management. J Ophthalmol (2014) 0.86
Long-term therapy with low dose cyclosporin A in ocular Behçet's disease. Doc Ophthalmol (2002) 0.85
AAV2-mediated combined subretinal delivery of IFN-α and IL-4 reduces the severity of experimental autoimmune uveoretinitis. PLoS One (2012) 0.79
[Ocular involvement in Behçet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a]. Ophthalmologe (2004) 0.77
Long-term efficacy and safety of interferon α-2a therapy in severe refractory ophthalmic Behcet's disease. Clin Rheumatol (2016) 0.76
Intraocular surgery under systemic interferon-alpha therapy in ocular Adamantiades-Behçet's disease. Graefes Arch Clin Exp Ophthalmol (2007) 0.76
Transverse myelitis in a patient with Behcet's disease: favorable outcome with a combination of interferon-alpha. Clin Rheumatol (2004) 0.75
A Clinical Picture of the Visual Outcome in Adamantiades-Behçet's Disease. Biomed Res Int (2015) 0.75
Vitrectomy and trabeculectomy combined with interferon alpha treatment in Adamantiades-Behçet's disease: a case report. Graefes Arch Clin Exp Ophthalmol (2003) 0.75
Possible association between Behçet's syndrome and chronic hepatitis C virus infection. N Engl J Med (1995) 2.83
A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med (1990) 2.77
Interferon-associated retinopathy. Arch Ophthalmol (1993) 2.73
Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease. Lancet (1989) 1.92
Interferon-alpha 2b for refractory ocular Behçet's disease. Lancet (1994) 1.65
The neglected role of type I interferon in the T-cell response: implications for its clinical use. Immunol Today (1996) 1.63
Retinal complications during interferon therapy for chronic hepatitis C. Am J Gastroenterol (1996) 1.60
Effectiveness of cyclosporin therapy for Behçet's disease. Arthritis Rheum (1985) 1.49
Anterior ischemic optic neuropathy secondary to interferon alfa. Arch Ophthalmol (1995) 1.20
Induction of Behçet's disease symptoms after dental treatment and streptococcal antigen skin test. J Rheumatol (1988) 1.06
Behçet's disease: activated T lymphocytes in retinal perivasculitis. Br J Ophthalmol (1992) 1.01
[Ocular prognosis in Behçet's disease]. J Fr Ophtalmol (1992) 1.01
CD4 and CD8 cell responses to herpes simplex virus in Behçet's disease. Clin Exp Immunol (1988) 0.98
Immunopathological aspects of Behçet's disease. Clin Exp Rheumatol (1996) 0.94
Cytotoxic T cells against herpes simplex virus in Behçet's disease. Clin Exp Immunol (1990) 0.90
Behçet's disease: epidemiology and eye manifestations in German and Mediterranian patients. Ger J Ophthalmol (1995) 0.88
Erosive arthritis and posterior uveitis in Behçet's disease: treatment with interferon alpha and interferon gamma. Clin Exp Rheumatol (1996) 0.87
Systemic interferon alpha 2b treatment in Behçet's syndrome. J Rheumatol (1994) 0.86
Behçet's disease in patients with chronic myelogenous leukemia: possible role of interferon-alpha treatment in the occurrence of Behçet's symptoms. Ann Hematol (1997) 0.86
[The HLA pattern in Adamantiades-Behçet's disease in Germany. Association of occurrence, clinical symptoms and follow-up in 39 patients]. Hautarzt (1993) 0.84
The association between HLA B5 and ocular involvement in Behçet's disease in southern Turkey. Acta Ophthalmol (Copenh) (1992) 0.84
Behçet's disease induced by interferon therapy for chronic myelogenous leukemia. J Rheumatol (1995) 0.84
Parvovirus B19 infection in Behçet's disease. Clin Exp Rheumatol (1996) 0.83
Severe necroziting vasculitis in a patient with hepatitis C virus infection treated by interferon. Clin Exp Rheumatol (1996) 0.81
Therapy of Behçet's disease. Ger J Ophthalmol (1996) 0.81
[Adamantiades-Behçet disease. Therapeutic administration of systemic recombinant interferon-alpha-2a]. Hautarzt (1993) 0.81
Beneficial effects of interferon-alpha 2b in Behçet's disease. Arthritis Rheum (1993) 0.80
Treatment of Behçet's disease. Curr Opin Rheumatol (1992) 0.78
[Occurrence and significance of autoantibodies in the course of interferon therapy of chronic hepatitis C]. Dtsch Med Wochenschr (1996) 0.78
[Absence of relationship between Behçet's disease and hepatitis B and C virus infection]. Med Clin (Barc) (1996) 0.77
EULAR recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 3.37
Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis. Br J Ophthalmol (2003) 2.20
Transscleral diode laser cyclophotocoagulation for the treatment of refractory glaucoma secondary to inflammatory eye diseases. Br J Ophthalmol (2000) 1.68
Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Rheumatol Int (2011) 1.64
[Fuchs uveitis syndrome--heterochromia is no "conditio sine qua non"]. Ophthalmologe (2005) 1.44
[Early clinical results with mycophenolate mofetil in immunosuppressive therapy of ocular pemphigoid]. Klin Monbl Augenheilkd (2001) 1.40
Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 1.32
The ocular surface and tear film and their dysfunction in dry eye disease. Surv Ophthalmol (2001) 1.31
Interferon as a treatment for uveitis associated with multiple sclerosis. Br J Ophthalmol (2005) 1.05
Mycophenolate mofetil in the treatment of uveitis in children. Br J Ophthalmol (2006) 1.02
Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis. Br J Ophthalmol (2009) 1.00
Epstein-Barr virus associated acute retinal necrosis. Br J Ophthalmol (2001) 0.99
[Severe eye involvement in pemphigus vulgaris]. Ophthalmologe (1995) 0.98
MAGIC or not MAGIC--does the MAGIC (mouth and genital ulcers with inflamed cartilage) syndrome really exist? A case report and review of the literature. Clin Exp Rheumatol (2006) 0.96
[Churg-Strauss syndrome]. Klin Monbl Augenheilkd (1999) 0.92
Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease. Rheumatology (Oxford) (2004) 0.90
[Anti-TNF-α treatment for uveitis. Analysis of the current situation]. Ophthalmologe (2011) 0.90
[Secondary ocular syphilis with chorioretinitis of the posterior pole - a case report]. Klin Monbl Augenheilkd (2001) 0.89
Maturation of thyroidal dendritic cells in Graves' disease. Scand J Immunol (2002) 0.89
Ocular hypertension and glaucoma associated with scleritis and uveitis. Aspects of epidemiology, pathogenesis and therapy. Dev Ophthalmol (1999) 0.88
[Behçet's disease: uveitis-therapy with interferon alpha2a - prospective clinical study in 33 patients]. Klin Monbl Augenheilkd (2001) 0.87
MMF and eye disease. Lupus (2005) 0.87
Erosive arthritis and posterior uveitis in Behçet's disease: treatment with interferon alpha and interferon gamma. Clin Exp Rheumatol (1996) 0.87
[Drug-induced exudative erythema multiforme major with a chronic progressive course and bilateral blindness. Clinical and immunohistologic follow-up]. Klin Monbl Augenheilkd (1990) 0.86
[Optical coherence tomography in the diagnosis and follow-up of patients with uveitic macular edema]. Ophthalmologe (2004) 0.86
[New clinical and epidemiologic aspects of episcleritis and scleritis]. Ophthalmologe (1997) 0.86
[Inflammatory choroidal neovascularisations]. Klin Monbl Augenheilkd (2012) 0.85
HHV8 associated Kaposi's sarcoma during triple immunosuppressive treatment with cyclosporin A, azathioprine, and prednisolone for ocular Behçet's disease and complete remission of both disorders with interferon alpha. Ann Rheum Dis (2001) 0.85
[Conjunctival neuromas and prominent corneal nerve fibers as diagnostic indication of multiple endocrine disease]. Klin Monbl Augenheilkd (2001) 0.84
Comparative analysis of the association of HLA-B*51 suballeles with Behçet's disease in patients of German and Turkish origin. Tissue Antigens (2001) 0.84
Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Behçet's disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literature. Clin Exp Rheumatol (2005) 0.83
[Intraocular non-Hodgkin's lymphoma and its therapy-- a case series of ten patients]. Klin Monbl Augenheilkd (2004) 0.83
[Immunosuppressive therapy with mycophenolate mofetil (CellCept) in treatment of uveitis]. Ophthalmologe (2001) 0.83
[Cogan I syndrome: clinical aspects, therapy and prognosis]. Ophthalmologe (2000) 0.81
[Neurological complications in acute posterior multifocal placoid pigmentepitheliopathy (APMPPE) - a review with case report]. Klin Monbl Augenheilkd (2001) 0.81
[Chronic keratitis and autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome - a case report]. Klin Monbl Augenheilkd (2001) 0.81
Examination of orbital tissues in murine models of Graves' disease reveals expression of UCP-1 and the TSHR in retrobulbar adipose tissues. Horm Metab Res (2013) 0.81
Hepatic retinopathy: morphological features of retinal glial (Müller) cells accompanying hepatic failure. Acta Neuropathol (1995) 0.80
[Keratomalacia in rheumatoid arthritis: immunohistologic and enzyme histochemical studies]. Z Rheumatol (1991) 0.80
[Secondary glaucoma in uveitis]. Ophthalmologe (2010) 0.80
[Comments on the pathogenesis of Behçet's disease. A key to understanding new therapies?]. Ophthalmologe (2012) 0.80
Neuroendocrine alterations in uveitis patients. Graefes Arch Clin Exp Ophthalmol (1994) 0.79
Long-term oral therapy with valganciclovir in patients with Posner-Schlossman syndrome. Graefes Arch Clin Exp Ophthalmol (2013) 0.79
[Behçet's disease - ophthalmological and general aspects part I : etiology, pathogenesis and diagnostics]. Ophthalmologe (2012) 0.79
Current insights into animal models of Graves' disease and orbitopathy. Horm Metab Res (2013) 0.79
[Late recurrence of donor contamination-related candida glabrata endophthalmitis following penetrating keratoplasty]. Klin Monbl Augenheilkd (2009) 0.79
[Noise field findings in 24 patients with coronary heart disease]. Klin Monbl Augenheilkd (2000) 0.79
Randomized comparison of endoscopic palliation of malignant esophageal stenoses. Surg Endosc (1991) 0.78
[Lymphoma of the ocular adnexa]. Ophthalmologe (2015) 0.78
[Behcet's disease--ophthalmological and general aspects: Part 2: Therapy]. Ophthalmologe (2013) 0.78
[Ocular rosacea]. Hautarzt (2013) 0.78
Complete regression of retinal neovascularization after therapy with interferon alfa in Behçet's disease. Br J Ophthalmol (2000) 0.78
[Treatment of Behçet's disease yesterday and today]. Ophthalmologe (2012) 0.78
[Glaucoma and retinal surgery]. Ophthalmologe (2010) 0.78
Murine acute retinal necrosis. Trans Am Ophthalmol Soc (1991) 0.78
[Inhibitors of tumour necrosis factor-alpha for the treatment of arthritis and uveitis in childhood]. Klin Monbl Augenheilkd (2007) 0.77
Colour vision in normal subjects tested by the colour arrangement test 'Roth 28-hue desaturated'. Vision Res (1998) 0.77
[Ocular involvement in Behçet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a]. Ophthalmologe (2004) 0.77
Immunology and growth characteristics of ocular basal cell carcinoma. Graefes Arch Clin Exp Ophthalmol (2001) 0.77
[Clinical aspects, follow-up and results of cataract extraction in uveitis]. Ophthalmologe (1992) 0.77
[Janus-faced?: Effects and side-effects of interferon therapy in ophthalmology]. Ophthalmologe (2011) 0.77
[Intraocular (oculocerebral) non-Hodgkin lymphoma]. Ophthalmologe (2001) 0.77
[Clinical types of immunologic transplant reactions following perforating keratoplasty]. Fortschr Ophthalmol (1990) 0.76
Dysregulation of TNF/TNFR superfamily members: a systemic link between intra- and extrathyroidal manifestations in Graves' disease. Scand J Immunol (2006) 0.76
[Diagnostics in childhood uveitis: what tests for which uveitis?]. Klin Monbl Augenheilkd (2007) 0.76
[Cyclosporin A 2% eyedrops in therapy of atopic and vernal keratoconjunctivitis]. Ophthalmologe (2002) 0.76
The T393C polymorphism of the Galphas gene (GNAS1) is associated with the course of Graves' disease. Horm Metab Res (2009) 0.76
[Glaucoma and corneal transplantation]. Ophthalmologe (2010) 0.75
[Topical and systemic corticosteroid therapy for uveitis in childhood]. Klin Monbl Augenheilkd (2007) 0.75
[Familial uveitis. Forms and incidence in patients at the University Eye Hospital Tubingen]. Ophthalmologe (2003) 0.75
[Therapeutic vitrectomy in uveitis: current status and recommendations]. Ophthalmologe (2003) 0.75
[EBM analysis: classic DMARDs (disease-modifying antirheumatic drugs) and immunosuppressants in arthritis and uveitis]. Klin Monbl Augenheilkd (2007) 0.75
[Multifocal electroretinography in acquired macular dysfunction]. Klin Monbl Augenheilkd (1998) 0.75
Interferon-alpha--a new therapeutic option in refractory juvenile Behçet's disease with CNS involvement. Rheumatology (Oxford) (2008) 0.75
Riding on a carousel with IFN-alpha and TNF-alpha. Ocul Immunol Inflamm (1998) 0.75
[Scleromalacia associated with varicella-zoster virus]. Ophthalmologe (2008) 0.75
[Epidemic keratoconjunctivitis. Detecting adenoviruses]. Ophthalmologe (2005) 0.75
Oculomucocutaneous changes as paraneoplastic syndromes. Ger J Ophthalmol (1996) 0.75
[The glaucoma work group--an initiative of the Tübingen University Eye Clinic]. Klin Monbl Augenheilkd (1998) 0.75
Topical cyclosporine A (2%) eyedrops in the therapy of atopic keratoconjunctivitis and keratoconjunctivitis vernalis. Adv Exp Med Biol (2002) 0.75
[Diffuse xanthogranuloma as a cause of infantile heterochromia]. Klin Monbl Augenheilkd (1994) 0.75
[Relapsing, therapy refractory episcleritis, paraproteinemia and cutaneous-subcutaneous nodules on arm and hip: manifestations of a necrobiotic xanthogranuloma (NXG)]. Klin Monbl Augenheilkd (2004) 0.75
[Inflammatory glaucomas]. Klin Monbl Augenheilkd (2005) 0.75
[Diagnostic and therapeutic recommendations for mucous membrane pemphigoid of the eye]. Klin Monbl Augenheilkd (2005) 0.75
Perspectives in immunotherapy. Dev Ophthalmol (1999) 0.75
[Threshold-oriented suprathreshold perimetry and threshold value perimetry with the Tübigen CC Automated Perimeter. A comparative study]. Ophthalmologe (1998) 0.75
[High endothelial venules. Kinetics of the expression in IRBP-induced experimental autoimmune uveitis]. Ophthalmologe (1999) 0.75
[Primary pigment epithelial cysts of the iris]. Klin Monbl Augenheilkd (1999) 0.75
Complex behaviour of spiral waves induced by an alternating electric field. Chemphyschem (2001) 0.75